Glycyrrhiza uralensis has a potential for preventing or ameliorating gastric mucosal ulceration. To understand the molecular mechanism about the medicinal effect of G. uralensis, we isolated four single compounds from G. uralensis and one related compound and screened for the cellular protective effect against H2O2-induced damage in gastric epithelial AGS cells. Interestingly, we found that ammonium glycyrrhizinate (AG) prepared from glycyrrhizin dramatically protects AGS cells from H2O2-induced damage as measured by the integrity of actin cytoskeleton. AG also inhibited FeSO4-induced reactive oxygen radicals in a dose-dependent manner, suggesting the role for AG as a free radical scavenger. To better understand the protective role of AG at the transcriptional level, we performed genome-wide expression profiling using high-density oligonucleotide microarrays, followed by validation using RT-PCR. Among the 33,096 genes that were screened in the microarray, 936 genes were found to be differentially expressed in a statistically significant manner in the presence or absence of H2O2 and AG. Among the 936 genes, 51 genes were differentially expressed at least 3-fold in response to the H2O2 treatment. AG blocked the expression of genes related to apoptotic cell death (GDF15, ATF3, TNFRSF10A, NALP1) or oxidative stress path-ways (HMOX1) which was elevated in response to H2O2 treatment, suggesting a potential protective role for AG in oxidative stress-induced cell death. Collectively, current results demonstrate that AG is a novel antioxidant that could be effective for the treatment of gastric diseases related to the oxidative stress-induced mucosal damage.
Get full access to this article
View all access options for this article.
References
1.
Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem64:97–112, 1995.
2.
Manna SK, Aggarwal BB. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13. J Biol Chem273:33333–33341, 1998.
3.
Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Over-expression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem273:13245–13254, 1998.
4.
Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med30:287–298, 2001.
5.
Welsh MJ, Shasby DM, Husted RM. Oxidants increase paracellular permeability in a cultured epithelial cell line. J Clin Invest76:1155–1168, 1985.
6.
Banan A, Fields JZ, Zhang Y, Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol280:G1234–1246, 2001.
7.
Smoot DT, Elliott TB, Verspaget HW, Jones D, Allen CR, Vernon KG, Bremner T, Kidd LC, Kim KS, Groupman JD, Ashktorab H. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis21:2091–2095, 2000.
8.
Yoshida N, Yoshikawa T, Iinuma S, Arai M, Takenaka S, Sakamoto K, Miyajima T, Nakamura Y, Yagi N, Naito Y, Mukai F, Kondo M. Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig Dis Sci41:1139–1144, 1996.
9.
Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H. Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori. J Clin Gastroenterol20 Suppl 2:S93–96, 1995.
10.
Ilizarov AM, Koo HC, Kazzaz JA, Mantell LL, Li Y, Bhapat R, Pollack S, Horowitz S, Davis JM. Overexpression of manganese superoxide dismutase protects lung epithelial cells against oxidant injury. Am J Respir Cell Mol Biol24:436–441, 2001.
11.
Sakurai MH, Matsumoto T, Kiyohara H, Yamada H. Detection and tissue distribution of anti-ulcer pectic polysaccharides from Bupleurum falcatum by polyclonal antibody. Planta Med62:341–346, 1996.
12.
Hsiang CY, Lai IL, Chao DC, Ho TY. Differential regulation of activator protein 1 activity by glycyrrhizin. Life Sci70:1643–1656, 2002.
13.
Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem10:155–171, 2003.
14.
Yano S, Harada M, Watanabe K, Nakamaru K, Hatakeyama Y, Shibata S, Takahashi K, Mori T, Hirabayashi K, Takeda M, et al. Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models. Chem Pharm Bull (Tokyo)37:2500–2504, 1989.
15.
Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer79:1494–1500, 1997.
16.
van Rossum TG, Vulto AG, Hop WC, Schalm SW. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol96:2432–2437, 2001.
17.
Saitoh T, Shibata S. Chemical studies on the oriental plant drugs. XXII. Some new constituents of licorice root. (2). Glycyrol, 5-O-methyl-glycyrol and isoglycyrol. Chem Pharm Bull (Tokyo)17:729–734, 1969.
18.
Wang CL, Zhang RY, Han YS, Dong XG, Liu WB. [Chemical studies of coumarins from Glycyrrhiza uralensis Fisch]. Yao Xue Xue Bao26: 147–151, 1991.
19.
Yang L, Liu YL, Lin SQ. [HPLC analysis of flavonoids in the root of six Glycyrrhiza species]. Yao Xue Xue Bao25:840–848, 1990.
20.
Shim SB, Kim NJ, Kim DH. Beta-glucuronidase inhibitory activity and hepatoprotective effect of 18 beta-glycyrrhetinic acid from the rhizomes of Glycyrrhiza uralensis. Planta Med66:40–43, 2000.
21.
Kondratenko RM, Baltina LA, Mustafina SR, Vasil’eva EV, Pompei R, Deidda D, Pliasunova OA, Pokrovskii AG, Tolstikov GA. [The synthesis and antiviral activity of glycyrrhizic acid conjugates with alpha-D-glucosamine and some glycosylamines]. Bioorg Khim30: 308–315, 2004.
22.
Kondratenko RM, Baltina LA, Vasil’eva EV, Nasyrov Kh M, Kireeva RM, Baschenko N, Fridman SM, Tolstikov GA. [Synthesis and immunomodulating activity of new diglycopeptides of glycyrrhizinic acid and its 30-methyl ester]. Bioorg Khim30:168–173, 2004.
23.
Kondratenko RM, Baltina LA, Vasil’eva EV, Ismagilova AF, Nasyrov Kh M, Baschenko N, Kireeva RM, Fridman SM, Tolstikov GA. [Synthesis and immunostimulating activity of cysteine-containing glycopeptide derivatives of glycyrrhizic acid]. Bioorg Khim30:61–67, 2004.
24.
Royall JA, Ischiropoulos H. Evaluation of 2′,7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys302:348–355, 1993.
25.
Greene BT, Thorburn J, Willingham MC, Thorburn A, Planalp RP, Brechbiel MW, Jennings-Gee J, Wilkinson JT, Torti FM, Torti SV. Activation of caspase pathways during iron chelator-mediated apoptosis. J Biol Chem277:25568–25575, 2002.
26.
Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med28:727–738, 2000.
27.
Kadara H, Schroeder CP, Lotan D, Pisano C, Lotan R. Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis. Cancer Biol Ther5:518–522, 2006.
28.
Mashima T, Udagawa S, Tsuruo T. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol188:352–358, 2001.
29.
Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol34:613–622, 2004.
30.
Guyton KZ, Spitz DR, Holbrook NJ. Expression of stress response genes GADD153, c-jun, and heme oxygenase-1 in H2O2- and O2-resistant fibroblasts. Free Radic Biol Med20:735–741, 1996.
31.
Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res31:335–340, 1999.
32.
Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol18 Suppl:73–81, 2004.
33.
Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A93:10614–10619, 1996.
34.
Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol14:1675–1680, 1996.
35.
Frederick Lo C, Ning X, Gonzales C, Ozenberger BA. Induced expression of death domain genes NALP1 and NALP5 following neuronal injury. Biochem Biophys Res Commun366:664–669, 2008.
36.
Erdmann K, Grosser N, Schroder H. L-methionine reduces oxidant stress in endothelial cells: role of heme oxygenase-1, ferritin, and nitric oxide. AAPS J7:E195–200, 2005.
37.
Gao M, Kondo F, Murakami T, Xu JW, Ma N, Zhu X, Mori K, Ishida T. 1-Aminocyclopropanecarboxylic acid, an antagonist of N-methyl-D-aspartate receptors, causes hypotensive and antioxidant effects with upregulation of heme oxygenase-1 in stroke-prone spontaneously hypertensive rats. Hypertens Res30:249–257, 2007.
38.
Koga K, Kawashima S, Shibata N, Takada K, Murakami M. Preparation and rectal absorption of highly concentrated glycyrrhizin solution. Biol Pharm Bull26:1299–1305, 2003.
39.
Antov G, Khalkova Z, Mikhailova A, Zaikov K, Burkova T. [The toxicological characteristics of ammonium glycyrrhizinate (glycyram). A study of its acute and subacute toxicity]. Eksp Klin Farmakol60:65–67, 1997.
